Yoshinori Fujimura; Kana Kurihara; Megumi Ida; Reia Kosaka; Daisuke Miura; Hiroyuki Wariishi; Mari Maeda-Yamamoto; Atsushi Nesumi; Takeshi Saito; Tomomasa Kanda; Koji Yamada; Hirofumi Tachibana

Summary

Yoshinori Fujimura; Kana Kurihara; Megumi Ida; Reia Kosaka; Daisuke Miura; Hiroyuki Wariishi; Mari Maeda-Yamamoto; Atsushi Nesumi; Takeshi Saito; Tomomasa Kanda; Koji Yamada; Hirofumi Tachibana Metabolomics-Driven Nutraceutical Evaluation of Diverse Green Tea Cultivars…

Green tea constituents show various biological and pharmacological activities, such as anti-carcinogenic, anti-metastatic, anti-oxidative, anti-hypertensive, and anti-hypercholesterolemic activities [2] – [3] . The chemical components of tea vary according to species/cultivar, environment, growth, storage conditions, and leaf quality [4] . In most cases, the quality and bioactive functions (i.e., the health promotion effects in human and animal models) of tea are defined by their specific compositions.
Source: Wikisource

Yoshinori Fujimura; Kana Kurihara; Megumi Ida; Reia Kosaka; Daisuke Miura; Hiroyuki Wariishi; Mari Maeda-Yamamoto; Atsushi Nesumi; Takeshi Saito; Tomomasa Kanda; Koji Yamada; Hirofumi Tachibana Metabolomics-Driven Nutraceutical Evaluation of Diverse Green Tea Cultivars…

To test bioactivity we investigated the ability of leaf extracts to inhibit thrombin-induced MRLC in human umbilical vein endothelial cells (HUVECs) , as a potential hallmark of vascular endothelial dysfunction. In addition, analyses of metabolic data from all tea extracts clearly discriminated green tea cultivars according to their bioactivity. Using regression analysis, we constructed a model to predict the bioactivity of tea cultivars on the basis of their metabolic data.
Source: Wikisource

Yoshinori Fujimura; Kana Kurihara; Megumi Ida; Reia Kosaka; Daisuke Miura; Hiroyuki Wariishi; Mari Maeda-Yamamoto; Atsushi Nesumi; Takeshi Saito; Tomomasa Kanda; Koji Yamada; Hirofumi Tachibana Metabolomics-Driven Nutraceutical Evaluation of Diverse Green Tea Cultivars…

Here, we showed for the first time the ability of numerous green tea cultivars to inhibit MRLC phosphorylation in HUVECs (Fig. 1) . Although further animal and human studies are required, these results suggest that intake of green tea may help to prevent cardiovascular diseases such as atherosclerosis via a novel therapeutic target, i.e., the inhibition of MRLC phosphorylation. A combination of certain SR-specific polyphenols with an extract from the non-bioactive cultivar YB inhibited MRLC phosphorylation (Fig. 8) .
Source: Wikisource

Get perspective with Kwize: daily news enlightened by great literature